Medtronic
MDT
1,958 hedge funds and large institutions have $127B invested in Medtronic in 2020 Q4 according to their latest regulatory filings, with 255 funds opening new positions, 832 increasing their positions, 653 reducing their positions, and 84 closing their positions.
204% more first-time investments, than exits
New positions opened: 255 | Existing positions closed: 84
27% more repeat investments, than reductions
Existing positions increased: 832 | Existing positions reduced: 653
13% more funds holding in top 10
Funds holding in top 10: 62 → 70 (+8)
13% more capital invested
Capital invested by funds: $113B → $127B (+$14.2B)
8% more funds holding
Funds holding: 1,810 → 1,958 (+148)
0.25% less ownership
Funds ownership: 80.98% → 80.73% (-0.25%)
13% less call options, than puts
Call options by funds: $878M | Put options by funds: $1.01B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$317M |
| 2 |
JP Morgan Chase
New York
|
+$315M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$298M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$282M |
| 5 |
Bank of New York Mellon
New York
|
+$168M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$636M |
| 2 |
BlackRock
New York
|
-$557M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$496M |
| 4 |
State Street
Boston,
Massachusetts
|
-$227M |
| 5 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$205M |
MDT Hedge Fund Activity: Q4 2020 in Review
1,958 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2020, worth a combined $127B — up 13% from $113B a quarter earlier.
Buyers outnumbered sellers: 255 funds opened new MDT positions and 84 closed out — a net gain of 171 holders — while 832 added to existing stakes and 653 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $317M. The largest seller was Wellington Management Group, cutting an estimated $636M.
- 1,958 institutional investors held Medtronic (MDT) as of Q4 2020, up from 1,810 in Q3 2020.
- Funds reported $127B of Medtronic stock for Q4 2020, up 13% quarter-over-quarter.
- 255 funds opened new Medtronic positions in Q4 2020 and 84 closed out, a net change of +171 holders.
- The largest Medtronic buyer in Q4 2020 was T. Rowe Price Associates, an estimated $317M added.
- The largest Medtronic seller in Q4 2020 was Wellington Management Group, an estimated $636M sold.
Based on aggregated 13F filings for Q4 2020.